We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$405M -$17.2M -301,128 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$294M +$52.9M +927,970 +18%
BlackRock
3
BlackRock
New York
$256M +$12M +210,215 +4%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$218M -$12.3M -215,964 -4%
FCM
5
Farallon Capital Management
California
$173M +$9.07M +159,000 +5%
Temasek Holdings
6
Temasek Holdings
Singapore
$137M -$62.3M -1,092,944 -28%
State Street
7
State Street
Massachusetts
$122M -$44.1M -773,918 -23%
MM
8
MWG Management
British Virgin Islands
$112M – – –
RG
9
Redmile Group
California
$84.5M -$4.39M -76,900 -4%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$52.6M +$7.83M +137,252 +14%
Goldman Sachs
11
Goldman Sachs
New York
$50.1M +$5.58M +97,749 +10%
DTC
12
Deep Track Capital
Connecticut
$47.6M -$14.3M -250,000 -20%
HH
13
HSG Holding
Hong Kong
$37.9M – – –
JP Morgan Chase
14
JP Morgan Chase
New York
$36M +$930K +16,296 +2%
Northern Trust
15
Northern Trust
Illinois
$28.8M +$2.42M +42,337 +8%
BG
16
Bellevue Group
Switzerland
$27.2M -$51.3K -900 -0.2%
Morgan Stanley
17
Morgan Stanley
New York
$24.8M -$4.7M -82,370 -14%
Sumitomo Mitsui Trust Group
18
Sumitomo Mitsui Trust Group
Japan
$24.3M +$12.5M +218,969 +75%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$23.9M +$1.64M +28,764 +6%
NAMA
20
Nikko Asset Management Americas
New York
$23.8M +$12.5M +218,969 +75%
Norges Bank
21
Norges Bank
Norway
$22.3M +$1.09M +19,119 +4%
Charles Schwab
22
Charles Schwab
California
$21.5M +$3.11M +54,458 +14%
Baillie Gifford & Co
23
Baillie Gifford & Co
United Kingdom
$18.4M +$21.4M +374,545 +3,509%
CC
24
Casdin Capital
New York
$17.6M -$285K -5,000 -1%
YCM
25
Yiheng Capital Management
California
$17.3M – – –
1
2 3 4 5

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.